Prophylaxis of Venous Thromboembolism: Analysis of Cost Effectiveness

Overview

Journal Ann Surg

Specialty General Surgery

Date 1980 Feb 1

PMID 6767449

Citations 24

Authors

E W Salzman

G C Davies

Affiliations

Soon will be listed here.

Abstract

The rapidly expanding literature regarding prevention of venous thromboembolism is confusing and contradictory, but, when analysed in the aggregate, the collective experience permits a judgment about the relative efficacy of different prophylactic regimens in specific patient populations, who vary in the risk factors predisposing them to thromboembolism. The dollar cost of the several approaches to prevention and their consequences should also be a matter of concern. Efficacy and dollar cost together determine cost effectiveness, which provides a practical guide to selection of the prophylactic approach appropriate to an individual patient.

Citing Articles

Park B, Kim M, Kang S, Hong S Ann Surg Treat Res. 2016; 91(6):316-322.

PMID: 27904854 PMC: 5128378. DOI: 10.4174/astr.2016.91.6.316.

Venous thromboembolism in Pakistan: a neglected research agenda.

Khan A, Zafar S J Thromb Thrombolysis. 2012; 35(2):234-42.

PMID: 22915351 DOI: 10.1007/s11239-012-0799-2.

[An update on thrombosis prophylaxis in orthopaedic and accident surgery].

Grifka J, Haas S, Hovy L, Knopp W, Refior H, Schurmann M Orthopade. 2004; 33(7):762-73.

PMID: 15185072 DOI: 10.1007/s00132-004-0671-y.

Economics of thromboprophylaxis in total hip replacement surgery.

Harrison J, Warwick D, Coast J Pharmacoeconomics. 1997; 12(1):30-41.

PMID: 10169386 DOI: 10.2165/00019053-199712010-00004.

Cost effectiveness of the prevention and treatment of deep vein thrombosis and pulmonary embolism.

Anderson D, OBrien B Pharmacoeconomics. 1997; 12(1):17-29.

PMID: 10169385 DOI: 10.2165/00019053-199712010-00003.

References

KERNOHAN R, Todd C . Heparin therapy in thromboembolic disease. Lancet. 1966; 1(7438):621-3. DOI: 10.1016/s0140-6736(66)90822-1. View

ASKEY J . Hemorrhage during long-term anticoagulant drug therapy. 1. Intracranial hemmorrhage. Calif Med. 1966; 104(1):6-10. PMC: 1516184. View

Harris W, Salzman E, DESANCTIS R . The prevention of thromboembolic disease by prophylactic anticoagulation. A controlled study in elective hip surgery. J Bone Joint Surg Am. 1967; 49(1):81-9. View

IVINS J, BENSON W, BICKEL W, Nelson J . Arthroplasty of the hip for idiopathic degenerative joint disease. Surg Gynecol Obstet. 1967; 125(6):1281-4. View

OSullivan E, Hirsh J, McCarthy R, de Gruchy G . Heparin in the treatment of venous thrombo-embolic disease: administration, control and results. Med J Aust. 1968; 2(4):153-9. DOI: 10.5694/j.1326-5377.1968.tb29378.x. View

Flanc C, Kakkar V, Clarke M . The detection of venous thrombosis of the legs using 125-I-labelled fibrinogen. Br J Surg. 1968; 55(10):742-7. DOI: 10.1002/bjs.1800551007. View

Negus D, Pinto D, Le Quesne L, Brown N, Chapman M . 125-I-labelled fibrinogen in the diagnosis of deep-vein thrombosis and its correlation with phlebography. Br J Surg. 1968; 55(11):835-9. View

AMADOR E, Li T, Crane C . Ligation of inferior vena cava for thromboembolism. Clinical and autopsy correlations in 119 cases. JAMA. 1968; 206(8):1758-60. View

Flanc C, Kakkar V, Clarke M . Postoperative deep-vein thrombosis. Effect of intensive prophylaxis. Lancet. 1969; 1(7593):477-8. DOI: 10.1016/s0140-6736(69)91585-2. View

10.

London D, CROSFILL M . The effect of Dextran '70'* on post-operative deep venous thrombosis. Br J Clin Pract. 1969; 23(4):158-60. View

11.

Hartshorn J, Teale S, Faiz M . Dextran 75 and postoperative phlebitis. Evaluation of dextran 75 in the prophylaxis of postoperative thrombophlebitis, pulmonary embolism, and myocardial infarction. Arch Surg. 1969; 98(6):694-7. DOI: 10.1001/archsurg.1969.01340120042003. View

12.

SAWYER R . Clinical experiences with dextran treatment. Acta Chir Scand Suppl. 1968; 387:58-60. View

13.

Jansen H . Dextran as a prophylaxis against thromboembolism in general surgery. Acta Chir Scand Suppl. 1968; 387:86-7. View

14.

Stadil F . Macrodex prophylaxis in postoperative thrombosis. A prelininary communication. Acta Chir Scand Suppl. 1968; 387:88-90. View

15.

Kakkar V, HOWE C, Flanc C, Clarke M . Natural history of postoperative deep-vein thrombosis. Lancet. 1969; 2(7614):230-2. DOI: 10.1016/s0140-6736(69)90002-6. View

16.

BROWSE N, Hall J . Effect of dipyridamole on the incidence of clinically detectable deep-vein thrombosis. Lancet. 1969; 2(7623):718-20. DOI: 10.1016/s0140-6736(69)90429-2. View

17.

Allgood R, Cook J, Weedn R, Speed H, WHITCOMB W, Greenfield L . Prospective analysis of pulmonary embolism in the postoperative patient. Surgery. 1970; 68(1):116-22. View

18.

Pinto D . Controlled trial of an anticoagulant (warfarin sodium) in the prevention of venous thrombosis following hip surgery. Br J Surg. 1970; 57(5):349-52. DOI: 10.1002/bjs.1800570508. View

19.

Stadil F . Prevention of venous thrombosis. Lancet. 1970; 2(7662):50. DOI: 10.1016/s0140-6736(70)92519-5. View

20.

Tsapogas M, Miller R, PEABODY R, Eckert C . Detection of postoperative venous thrombosis and effectiveness of prophylactic measures studied with the fibrinogen 125-I technique. Arch Surg. 1970; 101(2):149-54. DOI: 10.1001/archsurg.1970.01340260053009. View